INNOVIVA, INC. Public Float
INNOVIVA, INC. (INVA) had Public Float of $1.26 billion as of 2025-06-30, per its 10-K/A filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $1.26B.
- 2024-06-30: Entity Public Float $899.11M.
- 2023-06-30: Entity Public Float $731.93B.
- 2022-06-30: Entity Public Float $923.93M; Entity Public Float as first filed $923.93B.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $1.26B 10-K/A · filed 2026-03-27 | |
| 2024-06-30 | $899.11M 10-K/A · filed 2025-03-24 | |
| 2023-06-30 | $731.93B 10-K/A · filed 2024-03-22 | |
| 2022-06-30 | $923.93M 10-K/A · filed 2023-03-20 | $923.93B 10-K · filed 2023-02-28 |
| 2021-06-30 | $840.85B 10-K/A · filed 2022-03-17 | |
| 2020-06-30 | $876.61M 10-K · filed 2021-02-25 | |
| 2019-06-28 | $1.01B 10-K/A · filed 2020-02-21 | |
| 2018-06-29 | $904.85M 10-K · filed 2019-02-19 | |
| 2017-06-30 | $980.94M 10-K · filed 2018-02-23 | |
| 2016-06-30 | $832.06M 10-K · filed 2017-02-28 | |
| 2015-06-30 | $636.99M 10-K · filed 2016-02-24 | |
| 2014-06-30 | $1.41B 10-K · filed 2015-02-27 | |
| 2013-06-30 | $1.66B 10-K · filed 2014-03-03 | |
| 2012-06-30 | $940.77M 10-K · filed 2013-02-26 | |
| 2011-06-30 | $961.10M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |